GlobeImmune (GBIM) Short Interest Ratio & Short Volume

Short interest is the volume of GlobeImmune shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 8,400 shares of GBIM short. Learn More on GlobeImmune's current short interest.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to GlobeImmune: Alvotech (0.07%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

Short selling GBIM is an investing strategy that aims to generate trading profit from GlobeImmune as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for GlobeImmune occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GBIM, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GBIM, twice per month. The most recent reporting period available is October, 15 2024.